Léna Tripet - Profile and Investment Details

Investor Profile

Léna Tripet is a Private Equity Firm, Venture Capital based in Switzerland with a diverse investment portfolio that includes companies such as Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma, Symetis, Kalypsys, S*Bio, Omeros, Evolva, Synaffix BV, ImVisioN Therapeutics, Nura, Telormedix, NovImmune, Bird Rock Bio, Athelas, Ambrx, Bellerophon Therapeutics, Miikana Therapeutics. Over time, Léna Tripet has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Léna Tripet is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Life Science, Biotech, Healthcare, Biotechnology, Food and Beverage, Switzerland-based Startups, Consulting, Renewable Energy, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Léna Tripet, as their portfolio suggests a familiarity and interest in this area.

Understanding Léna Tripet’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.